Press release2017.09.25

Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation

PRESS RELEASE “Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation”

Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation

ImmuniT Research Inc.

〒160-0022 東京都新宿区新宿4-3-17
FORECAST新宿SOUTH 3階